Robert Boyd

Rob is a highly experienced and successful senior scientist who has progressed multiple immunomodulatory antibodies to clinical development. His experience lies in developing targeted therapeutic approaches to novel targets in oncology, immune oncology and autoimmunity and progressing these antibodies to the clinic. Before joining ILC, Robert was the senior director of preclinical and project management at MiroBio.